Fig. 7From: The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinomaDrug sensitivities prediction based on ACSL1 expression in ccRCC. (A) The predicted IC50 values for ACSL1 high- and low-expression groups in ccRCC to Temsirolimus and Pictilisib treatment. (B) The predicted IC50 values for ACSL1 high- and low-expression groups in ccRCC to Pazopanib and Sorafenib treatment. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page